While many celebrated the FDA approval of Descovy for PrEP earlier this month, advocates wonder whether it will make biomedical HIV prevention more or less accessible to those most in need.
Personal injury lawsuit ads targeting social media have become daily sightings. But are they doing more harm than good?
The PrEP Access and Coverage Act would guarantee insurance coverage for PrEP and fund PrEP for the uninsured.
Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.
April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.
For LGBT Health Awareness Week, educator Tyunique Nelson argues that PrEP education and access for youth have to be a top priority.
E/C/F/TAF viability for dialysis patients; TAF safety following renal damage; mental health needs for American Indians; parenting desires of people with HIV.
HIV-positive donor, HIV-negative recipient; continuum of care after incarceration in U.S.; reduced bone mineral density among men with HIV under 50; discouraging anti-inflammatory findings for an antiplatelet agent.
Barring the unlikely event that a U.S. entity puts time and money into comparative trials, Cimduo can't cut into the PrEP portion of the Truvada market.
Brand Name: Truvada Other Name(s): FTC/TDF, emtricitabine/tenofovir DF Drug Class: Nucleoside Reverse Transcriptase Inhibitors